Invitrolize

Private

BelvauxHealthcare & Life Scienceshttps://invitrolize.com/

Last Round

Seed

May 14, 2025

Total Funding Raised

$1.28M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Invitrolize is a biotechnology company that provides advanced 3D in vitro models of the human alveolar barrier to identify respiratory sensitizers and irritants for the pharmaceutical, cosmetic, chemical, and consumer goods industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Compliance, Fashion & Beauty, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in vitro testinganimal testing alternativestoxicological testingcontract research organizationCROskin sensitizationreconstructed human epidermiscruelty-free testingregulatory compliancesafety assessmenthuman cell-based assaysNAMsnew approach methodologiesbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Invitrolize Comps

Public and private peers based on sector, stage, and business model.

Invitrolize comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Invitrolize Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	May 14, 2025
Accelerator	Oct 19, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Asier Sesma

Chief Operating Officer

Executive Team

Invitrolize Investors

Notable investors and investment history

Invitrolize investors
Investor	Rounds
Expon Capital	Seed
Luxembourg's Ministry of the Economy	Accelerator
Fit 4 Start	Accelerator, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 20, 2026
Monthly visitors increased 79% MoM.
May 14, 2025
$1.12M round led by Expon Capital

View all signals

Invitrolize Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Invitrolize Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Invitrolize's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelvaux

Employee Range5

Year Founded2021

Last FundingMay 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.